Novel Small Molecule Inhibitor Against IGF2BP3 with Potent Anti-Leukemic Activity
Sign Up to like & getrecommendations! Published in 2024 at "Blood"
DOI: 10.1182/blood-2024-204473
Abstract: Background:RNA binding proteins have emerged as promising therapeutic targets in cancer because of their role as important mediators of oncogenesis. The RNA binding protein IGF2BP3 is an oncofetal protein expressed during fetal development, absent or… read more here.
Keywords: mll; mll af4; i3in 002; igf2bp3 ... See more keywords